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This study was designed to evaluate the effects of Bauhinia forficata Link subsp. pruinosa (BF) tea on oxidative stress and liver
damage in streptozotocin (STZ)-induced diabetic mice. Diabetic male mice have remained 30 days without any treatment. BF
treatment started on day 31 and continued for 21 days as a drinking-water substitute.We evaluated (1) BF chemical composition; (2)
glucose levels; (3) liver/bodyweight ratio and liver transaminases; (4) reactive oxygen species (ROS), lipid peroxidation, and protein
carbonylation in liver; (5) superoxide dismutase (SOD) and catalase (CAT) activities in liver; (6) 𝛿-aminolevulinate dehydratase
(𝛿-ALA-D) and nonprotein thiols (NPSH) in liver; (7) Nrf2, NQO-1, and HSP70 levels in liver and pancreas. Phytochemical
analyses identified four phenols compounds. Diabetic mice present high levels of NQO-1 in pancreas, increased levels of ROS
and lipid peroxidation in liver, and decrease in CAT activity. BF treatment normalized all these parameters. BF did not normalize
hyperglycemia, liver/body weight ratio, aspartate aminotransferase, protein carbonyl, NPSH levels, and 𝛿-ALA-D activity. The
raised oxidative stress seems to be a potential mechanism involved in liver damage in hyperglycemic conditions. Our results
indicated that BF protective effect could be attributed to its antioxidant capacity, more than a hypoglycemic potential.
1. Introduction
Historically, basic therapy for treating several diseases in-
cludes the use of medicinal plants. Vegetable species with
medicinal power have considered complex mixtures of bio-
logically active products, and usually many of them are
responsible for their biological properties [1]. Therefore,
many plants considered medicinal have been used in folk
medicine to treat diabetes mellitus (DM) [2]. Among these is
Bauhinia forficata (BF) (Leguminosae, Fabaceae), popularly
known as “paw of cow” [3].
In Brazil, the tea (infusion) of BF leaves is an impor-
tant alternative treatment for people with DM [2]. The BF
genus comprises about 300 species found especially in the
tropical regions of the planet [3]. Besides their possible
hypoglycemic potential, considerations about the antioxidant
and hepatoprotective activities of some Bauhinia species have
been postulated. For example, extracts of Bauhinia forficata
Link and Bauhinia cheilandra showed antidiabetic activity
in STZ and alloxan-induced diabetic rats [4–6]. Already,
the antioxidant and hepatoprotective activity was previously
demonstrated for Bauhinia forficata Link, Bauhinia racemosa
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Lam, and Bauhinia variegata [7–9]. However, we did not find
in scientific literature studies withmice or rats that investigate
the sameBauhinia species thatwe use here (Bauhinia forficata
Link subsp. pruinosa (Vogel) Fortunato &Wunderlin).
Biological properties of Bauhinia species have been
attributed to its phenolic compounds. In this context,Bauhin-
ia forficata Link subsp. pruinosa are able to scavenge reactive
oxygen species (ROS) because it contains flavonoids among
its constituents (especially derivatives of quercetin and
kaempferol) [10, 11]. These characteristics can be extremely
important in diseases where there is an increase in oxidative
stress, as in DM and its complications.
Indeed, chronic hyperglycemia in DM has related to
a bigger ROS production and severe oxidative damage in
different tissues, including the liver (for a review see [12]).
Increased ROS has been known to induce changes in expres-
sion and activity of antioxidant enzymes superoxide dismu-
tase (SOD) and catalase (CAT), as well as thiol oxidation
and lipid peroxidation [12]. Furthermore, previous reports
showed that, in experimental models of DM, the sulfhydryl-
containing enzyme 𝛿-aminolevulinate dehydratase (𝛿-ALA-
D) was inhibited [13–15].
Moreover, increases in ROS production, both in liver
and in pancreas, stimulate expression of factors related to
cellular antioxidant response, such as NF-E2-related nuclear
factor erythroid-2 (Nrf2), NADPH quinone oxidoreductase
1 (NQO-1), and heat shock protein 70 (HSP70) [16, 17].
According to Yeo et al. [18], antioxidant and chemical stress,
including chemical DM induction in mice, increases NQO-1
expression.
Therefore, the aim of this study was to evaluate the effects
of Bauhinia forficata Link subsp. pruinosa (Vogel) Fortunato
&Wunderlin (infusion) (BF tea) treatment on oxidative stress
and liver damage in diabetic mice. Among the parameters
evaluated were the glycaemia, ROS production, lipid peroxi-
dation, protein carbonylation, and nonprotein thiols levels in
liver, as well as the activities of enzymes 𝛿-ALA-D, SOD, and
CAT in liver. Moreover, we evaluate the Nrf2, NQO-1, and
HSP70 expression in liver and, additionally, in pancreas.
2. Materials and Methods
2.1. Chemicals. Sigma-Aldrich Chemical Co. (St. Louis, MO)
supplied Ellman’s reagent (DTNB) and streptozotocin. Lab-
test (Minas Gerais, Brazil) supplied commercial kits. Other
reagents were obtained from local suppliers.
2.2. Bauhinia forficata (BF) Preparation. BF leaves were
collected in September (spring) of 2014 in southern Brazil
(29∘44󸀠58.8󸀠󸀠S 57∘05󸀠01.7󸀠󸀠W). Botanical identification of BF
leaves samples was confirmed and a voucher specimen
(number ICN 167491;B. forficataLink subsp. pruinosa (Vogel)
Fortunato &Wunderlin) was deposited at ICNHerbarium of
Federal University of Rio Grande do Sul (Brazil).
BF tea was prepared with naturally dried leaves in a
1mg/mLproportion (weight of dried leaves/volumeofwater),
described by Salgueiro et al. [11].
2.3. Chromatographic Analyses. Chromatographic analyses
byHPLCwere conducted, described in [11, 19], using a Promi-
nence Liquid Chromatograph (Shimadzu, Kyoto, Japan).This
apparatus is equipped with an SLC-10A controller, LC-20AD
pump, SIL-10AF autosampler, and SPD-M10A PDA detector.
An ODS-Hypersil Thermo Scientific C18 column (250 ×
4.6mm i.d., 5 𝜇m particle size) (Bellefonte, United States)
was used. Mobile phase consisted of water containing 0.05%
phosphoric acid (A) and acetonitrile (B) at a flow rate of
0.8mLmin−1 using the following gradients: 0.1–23min, 10–
40% of solvent B in A and 23.01–40min, 10% solvent B, and
90% solvent A. Detection was done on a diode array detector
(DAD) set at 340 nm and the injection volume was 20𝜇L.
The HPLC system was operated at 25 ± 1∘C. Runs were made
in triplicate. The reference standard chemical composition
for BF tea was established previously by our group, identify-
ing the compounds quercetin-3-O-(2-rhamnosyl) rutinoside,
kaempferol-3-O-(2-rhamnosyl) rutinoside, quercetin-3-O-
rutinoside, and kaempferol-3-O-rutinoside [11, 19].
2.4. Diabetes Mellitus (DM) Induction and BF Treatment.
Committee on the Ethics of Animal Experiments approved
this study (permit number 001/2012). All experiments were
conducted with the minimum number of animals and in
obedience to the guidelines for biomedical research stated
by the Brazilian Societies of Experimental Biology. Animals
were maintained in an enriched environment with a room-
controlled temperature, 12 h light-dark cycle, and food and
water available ad libitum.
Three-monthmale Swiss albinomice (30–35 grams) were
divided into four different groups with six animals for each
group:
(1) Control received only citrate buffer intraperitoneally
(i.p.) and drank water throughout the period.
(2) DM received a single STZ dose (150mg/kg) i.p. and
drank water throughout the period.
(3) BF received only citrate buffer i.p., drankwater during
30 days, and afterwards drank BF tea (1mg/mL)
during 21 days.
(4) DM + BF received a single STZ dose (150mg/kg) i.p.,
drank water during 30 days, and afterwards drank BF
tea (1mg/mL) during 21 days.
STZ was freshly prepared in citrate buffer (0.05M, pH
4.5), and before STZ administration the animals were fasted
for a period of four hours. STZ dose was established,
proposed by Animal Models of Diabetic Complications
Consortium [20], in order to induce a severe hyperglycemia
in mice. Five days after STZ injection the hyperglycemia was
confirmed by collecting a tail drop of blood and usingACCU-
Check Active (Roche Diagnostics) glucometer.
The BF concentration (approximately 313mg/kg of body
weight) was established after evaluation of liquid intake of
diabetic mice in metabolic cage (9.4± 2.24mL of tea per day)
and body weight mean (0.030 kg). This dose is in accordance
with previous studies that investigated the hypoglycemic and
hepatoprotective activity of otherBauhinia species [4–6, 8, 9].
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BF treatment started on day 31 and continued for 21 days in
drinking water.
2.5. Tissue Preparation for Biochemical Analyses. After the
period of treatment, animals were killed by cardiac puncture.
This procedure was performed under enough ether anesthe-
sia to ameliorate mice suffering. Mice livers were removed
and carefully washed, and part of them were weighted and
homogenized in 1 : 10 ratio of tissue to cold NaCl (0.9%). The
homogenates were centrifuged at 4000 g for 10min at 4∘Cand
the supernatants (S1) collected for biochemical analyses. All
the biochemical analyses were performed in the same day of
euthanasia. The liver and body weight were used to evaluate
the liver weight/body weight ratio.
2.6. Analysis of Glucose Levels and Liver Transaminases.
Blood was collected in heparinized tubes by cardiac puncture
after fasting for 6 hours. After centrifugation, levels of glucose
and liver transaminases were determined in plasma using a
commercial kit (Labtest, Minas Gerais/Brazil).
2.7. Assessment of 2,7-Dichlorofluorescein (DCFH) Oxidation.
Indirect quantification of reactive oxygen species (ROS)
production was determined in S1 samples by evaluation
of dichlorofluorescein reactive species (DCF-RS) levels,
proposed by Myhre et al. [21]. Briefly, an aliquot of S1
(100 𝜇L) were added to a medium containing Tris-HCl buffer
(0.01mM, pH 7.4) and DCFH-DA (7𝜇M). This medium
was incubated in the dark for 1 h until fluorimetric analysis
(Ex: 488 nm; Em: 520 nm). The results were stated as DCF
fluorescence intensity, corrected by protein content, and
expressed as percentage of control.
2.8. Thiobarbituric Acid Reactive Species (TBA-RS) Levels.
Lipid peroxidationwas assayed by adding S1 samples (100 𝜇L)
to a medium containing 8.1% sodium dodecyl sulfate, acetic
acid buffer (pH 3.5), and 0.8% aqueous solution of thiobar-
bituric acid, proposed by Ohkawa et al. [22]. After heating
at 95∘C for 60min, the red pigment produced was measured
spectrophotometrically at 532 nm.The results were calculated
using a standard curve constructed with malondialdehyde
(MDA) at known concentrations and corrected by protein
content.The results were expressed as nanomoles ofMDAper
milligram of protein.
2.9. Protein Carbonyl Levels. Protein carbonyl was mea-
sured in S1 samples, proposed by Levine et al. [23].
Briefly, an aliquot of S1 (200𝜇L) were derivatized using
2,4-dinitrophenylhydrazine (DNPH). DNPH reaction pro-
teins were precipitated with an equal volume of 20%
(w/v) trichloroacetic acid and washed three times with an
ethanol/ethyl acetate mixture (1 : 1). Finally, the precipitates
were dissolved in 6M guanidine HCl solution. Protein
carbonyl levels were determined spectrophotometrically at
370 nm, against blanks. The results were calculated using
the molar extinction coefficient of DNPH, corrected by
protein content, and expressed as nanomoles of carbonyl per
milligram of protein.
2.10. Superoxide Dismutase (SOD) Enzyme Activity. SOD
enzyme activity was determined in S1 samples, proposed
by Kostyuk and Potapovich [24]. This method is based
on the capacity of SOD in inhibiting quercetin autooxida-
tion. Briefly, S1 aliquots (25𝜇L) were added to a medium
containing 0.016M phosphate buffer, 0.8mM N,N,N’,N’-
Tetramethylethylenediamine, and 0.08mM EDTA (final pH
of the medium was 10). The kinetic analysis of SOD was
measured spectrophotometrically at 406 nm after quercetin
addition (1.5mg of quercetin in 10mL of N,N-Dimethylfor-
mamide). The results were corrected by protein content and
expressed as unit per milligram of protein. One unit of SOD
activity is defined as the amount of enzyme that inhibited the
quercetin oxidation reaction by 50% of maximal inhibition.
Fifty percent inhibition was produced by approximately
1.5 ng/mL of pure enzyme [17].
2.11. Catalase (CAT) Enzyme Activity. CAT enzyme activity
was determined in S1 samples, proposed by Aebi [25]. This
method is based on the rate of hydrogen peroxide (H
2
O
2
)
degradation by the action of CAT. Briefly, S1 aliquot (20𝜇L)
was added to a medium containing potassium phosphate
buffer (50mM, pH 7.4) and H
2
O
2
(1mM). The kinetic
analysis of CAT was measured spectrophotometrically at
240 nmafterH
2
O
2
addition.The results were calculated using
themolar extinction coefficient ofH
2
O
2
, corrected by protein
content, and expressed as nmol H
2
O
2
/mg protein/min.
2.12. Delta-Aminolevulinic Acid Dehydratase (𝛿-ALA-D)
Enzyme Activity. 𝛿-ALA-D enzyme activity was determined
in S1 samples, according to Sassa [26]. This method is
based in analysis of porphobilinogen (PBG) formation after
𝛿-aminolevulinic acid addition. Briefly, S1 samples (100 𝜇L)
were mixed with 𝛿-aminolevulinic acid (12mM initial
concentration).The tubes were incubated for 60min at 37∘C.
The reaction was stopped by adding 10% trichloroacetic acid
with 10mMmercuric chloride. After centrifugation, an equal
volume of Ehrlich reagent was added to the supernatant,
and absorbance at 555 nm was recorded. The results were
corrected by protein content and expressed as nanomoles of
PBG per milligram of protein per hour of incubation.
2.13. Nonprotein Thiols (NPSH) Levels. NPSH levels were
determined according to Ellman [27]. Briefly, the S1 samples
were precipitated with 10% trichloroacetic acid (1 : 1) and
centrifuged at 4000 g for 10min at 4∘C to obtain supernatants
(S2). S2 (100 𝜇L) samples were added to a medium contain-
ing phosphate buffer (TFK 0.25mM, pH 7.4), and Ellman
reagent (DTNB 1mM). The yellow pigment produced was
measured spectrophotometrically at 420 nm.The results were
calculated in relation to a standard curve constructed with
glutathione (GSH) at known concentrations and corrected by
protein content. The results were expressed as nanomoles of
SH per milligram of protein.
2.14. Protein Content Determination. Protein content was
determined in S1 samples, proposed by Bradford [28], and
measured spectrophotometrically at 595 nm. Bovine serum
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albumin at known concentrations was used to construct a
standard curve.
2.15. Western Blot Analysis. Western blotting was performed
according to Posser et al. [29] with minor modifications.
Part of the liver and pancreas were homogenized at 4∘C
in a medium containing 50mM Tris, 1mM EDTA, 0.1mM
phenylmethylsulfonyl fluoride, 20mM Na
3
VO
4
, 100mM
sodium fluoride, and protease inhibitor cocktail (Sigma,
MO), pH 7.0.The homogenates were centrifuged at 1000 g for
10min at 4∘C and the supernatants (S1) collected. After pro-
tein determination (following Bradford [28]) using bovine
serum albumin as standard, 𝛽-mercaptoethanol and glycerol
were added to samples to a final concentration of 8 and
25%, respectively, and the samples were frozen in −80∘C
until further analysis. Proteins (2mg/mL) were separated
using SDS-PAGE with 10% gels and then electrotransferred
to nitrocellulose membranes as previously described [29].
Membranes were washed in Tris-buffered saline with Tween
(TBST; 100mM Tris-HCl, 0.9% NaCl, and 0.1% Tween-20,
pH 7.5) and incubated overnight (4∘C) with different primary
antibodies (Santa Cruz Biotechnology, TX), all produced in
rabbit (anti-Nrf2, anti-NQO-1, and anti-HSP70 anti-𝛽-actin;
1 : 1000 dilution in TBST). Following incubation, membranes
were washed in TBST and incubated for 1 h at 25∘C with
HRP-linked anti-rabbit-IgG secondary specific antibodies
(Sigma, MO). The immunoblots were visualized in the
Image Station 4000MM PRO using ECL reagent (Promega,
WI). Immunoreactive bands were quantified using the Scion
Image software and expressed as percentage of untreated
controls.
2.16. Statistical Analysis. Datawere expressed asmean± SEM
of the number of animals used in each experiment. Statistical
analysis was performed using two-way ANOVA and Tukey
post hoc test. Values of 𝑝 < 0.05 were considered statistically
significant. GraphPad prism6 softwarewas used for statistical
analysis and for plotting graphs.
3. Results
3.1. Chromatographic Profile. HPLC analysis of BF tea
revealed the following main compounds kaempferol-3-O-(2-
rhamnosyl) rutinoside (2) > quercetin-3-O-(2-rhamnosyl)
rutinoside (1) > quercetin-3-O-rutinoside (3) > kaempferol-
3-O-rutinoside (4) (Figure 1).
3.2. Glucose Levels. Diabetic mice had a significant increase
in the serum glucose levels, which were not reduced by BF
(Figure 2).
3.3. Liver Toxicity Evaluation. The liver/body weight ratio
was increased in diabetic mice when compared to control
group. These changes were not modified by BF treatment.
BF per se did not affect this parameter (Figure 3). Diabetic
mice had a significant increase in aspartate aminotransferase
(AST) level (Figure 4(a)) when compared to the control
group. This change was not modified by BF treatment.
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Figure 1: Chromatographic profile of B. forficata Link subsp.
pruinosa (Vogel) Fortunato &Wunderlin tea. Chemical compounds
identified Peak 1: quercetin-3-O-(2-rhamnosyl) rutinoside (reten-
tion time: 15.60min); Peak 2: kaempferol-3-O-(2-rhamnosyl) ruti-
noside (retention time: 16.70min); Peak 3: quercetin-3-O-rutinoside
(retention time: 17.40min); Peak 4: kaempferol-3-O-rutinoside
(retention time: 19.10min).
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Figure 2: Glucose levels (mg/dL) at the end of treatment. The ∗
indicates significant difference in comparison to control group (𝑝 <
0.05).
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Figure 3: Liver/body weight ratio (g) of diabetic mice treated with
BF. The ∗ indicates significant difference in comparison to control
group (𝑝 < 0.05).
Alanine aminotransferase (ALT) level (Figure 4(b)) was not
changed by any treatment.
3.4. LiverOxidative Stress Evaluation. BF treatmentwas effec-
tive in normalizing the increases in ROS (DCF-RS) and lipid
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Figure 4: Alanine aminotransferase (a) and aspartate aminotransferase (b) levels (U/L) of diabetic mice treated with BF. The ∗ indicates
significant difference in comparison to control group (𝑝 < 0.05).
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Figure 5: Liver dichlorofluorescein reactive species (DCF-RS) (a); thiobarbituric acid reactive species (TBA-RS) (b); and protein carbonyl
levels (c) of diabetic mice treated with BF. The ∗ indicates significant difference in comparison to control group (𝑝 < 0.05).
peroxidation (TBA-RS) levels observed in diabetic mice, to
the control levels (Figures 5(a) and 5(b), resp.). Furthermore,
diabetic mice had an increase in the carbonylated protein
levels (Figure 5(c)) that were only partially reduced by BF
treatment.
No difference in SOD activity was observed among
the groups (Figure 6(a)). However, the diabetic mice had a
significant decrease in CAT activity when compared to the
control group. This decrease was attenuated by BF treatment
(Figure 6(b)).
The activity of liver 𝛿-ALA-D was inhibited in diabetic
mice. The inhibition of 𝛿-ALA-D enzyme activity was not
modified by BF treatment (Figure 7(a)). Addition of a thiol
donor dithiothreitol (DTT) partially reactivated 𝛿-ALA-D,
however, without restoring the basal activity of 𝛿-ALA-D
(data not shown). The levels of nonprotein thiol groups
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Figure 6: Liver superoxide dismutase (SOD) (a) and catalase (CAT) (b) activities of diabetic mice treated with BF.The ∗ indicates significant
difference in comparison to control group (𝑝 < 0.05).
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Figure 7: Liver delta-aminolevulinic acid dehydratase (𝛿-ALA-D) activity (a) and nonprotein SH (NPSH) levels (b) in diabetic mice treated
with BF. The ∗ indicates significant difference in comparison to control group (𝑝 < 0.05).
(NPSH) were increased in diabetic mice and BF treatment
restores only partially this increase (Figure 7(b)).
3.5. Western Blot Analysis. Liver western blot showed that
Nrf2, NQO-1, or HSP70 protein levels were not altered in
diabetic mice or BF treatment when compared to the control
(Figure 8). In pancreas, an increase in NQO-1 levels was
observed, and BF treatment reduce these at levels lower than
the control group (Figure 9). No differences in the levels
of Nrf2 and HSP70 were observed among the groups in
pancreas.
4. Discussion
The present study was designed to investigate the effects of
Bauhinia forficata Link subsp. pruinosa (Vogel) Fortunato &
Wunderlin (BF) tea against oxidative stress and liver damage
in diabetic mice. In folk medicine, various species of BF have
been used to treat diabetes mellitus (DM) [2], especially due
to their possible hypoglycemic effect. Our results show BF tea
reduced liver oxidative stress in diabetic mice, although it did
not change the glycaemia.
In this context, the absence of hypoglycemic action of BF
tea may be due to the nonextraction of some compounds
in the aqueous fraction (infusion) or due to absence of
kaempferitrin compound (kaempferol-3,7-O-(r)-dirhamno-
side), pointed out as responsible for hypoglycemic action in
other Bauhinia species [10].
Our results show BF tea per se does not determine abnor-
mal hepatic growth or transaminases changes, indicating
possible absence of toxicity (Figures 3 and 4(a), 4(b)). On the
other hand,we had an increase inAST levels and in liver/body
weight ratio in diabetic mice. The increase in liver/body
weight ratiomay be due to the reduction of body weight (data
not shown), common in untreated diabetes [30]. Regarding
transaminases, both AST and ALT are highly concentrated
in the liver. However, ALT is localized only in the cellular
cytoplasm, whereas AST is cytosolic in a minor portion
and mitochondrial in a major portion. Furthermore, AST
is highly concentrated in zone 3 of the hepatic acinus, and
damage to this zone may indicate ischemic or toxic events,
resulting in greater AST levels [31]. In case of diabetes, hepatic
toxic events may occur in response to an excess in free fatty
acids [32] results of insulin impairment. Knownmechanisms
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for hepatic toxics events that increase transaminases levels
in diabetic state include cell membrane disruption, mito-
chondrial dysfunction, toxin formation, oxidative stress, and
recruited inflammatory cells [32].
We observe an increase in reactive oxygen species (ROS)
and lipid peroxidation levels (Figures 5(a) and 5(b), resp.),
indicating oxidative damage in liver.The assessment of DCF-
RS is well accepted to determine ROS levels, as well as
reactive nitrogen species able to oxidize the DCFH, a general
index of oxidative stress. Similarly, TBA-RS assay is a known
biomarker used to estimate lipid damage from cells and
tissues, and its increased levels are an indirect evidence of
high ROS production. Although BF tea treatment did not
modify the changes in liver/body weight ratio and AST
levels in diabetic mice, the plant was effective in reducing
DCF-RS and TBA-RS levels. These findings reinforce our
previously reported antioxidant activity of BF tea even at low
concentrations [11].The antioxidant activity of BF extracts has
been attributed to high levels of polyphenols and flavonoids
present in its composition [11, 33]. Here, we identify four
major compounds (Figure 1) that were previously reported
using liquid chromatography-electrospray ionization-mass
spectrometry (LC-ESI-MS) [11, 19]. Among the chemical
constituents identified in our extract, the quercetin and
kaempferol derivate have been extensively studied to have
antioxidant properties, such as reduction of TBA-RS levels
and control of antioxidant response [10, 11].
Our results also showed that there is an increase in
liver carbonylated protein levels (Figure 5(c)). This increase
is reduced only partially by BF treatment, and it is not
related with ROS levels that were controlled by BF treatment
(Figure 5(a)). Probably, a longer BF treatment might reduce
the protein carbonyl levels to control levels. This is possible
whereas carbonylated proteins have a long half-life and take
longer to suffer degradation when compared to normal
proteins.
Concerning liver antioxidant enzymes, we observed a sig-
nificant decrease in CAT activity in diabetic mice, which was
reverted by BF tea treatment (Figure 6(b)). No changes were
observed in liver SOD activity in diabetic mice. For instance,
changes in antioxidant enzymes activities or its return to
normal values following a previous decrease may occur as a
compensatorymechanism in response to a constant exposure
to increased oxidative stress, such as those determined by
prolonged hyperglycemia. This could explain the decreases
in SOD activity observed by some researchers and the normal
SOD activity observed by other investigators (for a review see
[12]).
We also observed a decrease in 𝛿-ALA-D enzyme activity
(Figure 7(a)), not related to a decrease in NPSH levels
(Figure 7(b)), in diabetic mice. Several studies report that
the 𝛿-ALA-D enzyme activity is reduced in hyperglycemic
conditions [13, 14, 34]. This occurs due to presence of thiol
groups in its structure, which are sensitive to oxidation.
This characteristic explains its use as a good oxidative stress
biomarker [13, 14]. In diabetic mice, we observed an increase
in thiol levels, probably due to a physiological compensatory
effect. In this context, the NPSH levels, glutathione (GSH)
as a major compound, increase to counteract the high ROS
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HSP70
𝛽-actin
Control BF DM DM + BF
Figure 8: Liver Nrf2, NQO-1, and HSP70 protein levels in diabetic
mice treated with BF. The data were normalized with 𝛽-actin
expression and expressed as % of control.
production [11]. GSH is a ubiquitous cellular three-peptide
antioxidant that acts as an intracellular buffer being responsi-
ble for themaintenance of the thiol redox balance [35]. In this
line, mainly three functional changes may lead to a 𝛿-ALA-D
enzyme activity reduction, namely, removal of divalent zinc
from its catalytic site (1); oxidation of its critical thiol groups
(2); or protein oxidation (3) [13, 14, 34]. Taking into account
that there were no thiol levels compromising and that the
SH donor dithiothreitol (DTT) only partially reactivated 𝛿-
ALA-D (data not shown) we believe that the mechanism of
inhibition was linked to protein oxidation. In fact, reducing
sugars can interact with critical lysine residues of 𝛿-ALA-D
catalytic site, oxidizing the lysine residues to disulfides and
inactivating the enzyme [34]. In this context, inhibition of 𝛿-
ALA-D in diabetes may be related to hyperglycemia [13, 14].
Here, the oxidative damage in liver seems to occur
without changes in Nrf2, HSP70, or NQO-1 protein levels
(Figure 8). Different in pancreas (target organ of STZ), we
observed changes in NQO-1 expression (Figure 9) that were
minimized by BF treatment. The enzyme NQO-1 is generally
considered as a detoxification enzyme and has been known to
protect 𝛽-cells against stressors, including the diabetogenic
agent STZ [18, 36]. There is evidence that NQO-1 knockout
mice present increased pancreatic 𝛽-cell death induced by
STZ [18]. Furthermore, both STZ and hyperglycemia have
been known to increase ROS production [12], and NQO-1
enzyme plays an important role as a superoxide scavenger
that may provide an additional level of protection against
ROS toxicity [36]. The increase observed in pancreas NQO-1
could be associatedwith a possible response against the xeno-
biotic injury determined by STZ. However, more studies are
necessary to highlight the reasons for increased expression of
NQO-1 in pancreas but not in liver.
Although we did not observe changes in Nrf2 protein
levels, the NQO-1 upregulation in pancreas and the elevated
levels of GSH in liver suggest an early activation of Nrf2-
antioxidant response element (ARE) pathway, probably in
response to increase in ROS levels. In fact, under stress-
ing condition, the transcription factor Nrf2 interacts with
ARE and upregulates antioxidative genes including NQO-
1, antioxidant enzymes, and GSH levels, which are very
important components of the cellular antioxidant defense
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Figure 9: Pancreas Nrf2, NQO-1, and HSP70 protein levels in diabetic mice treated with BF (a). Graphical representation of NQO-1 pancreas
protein levels (b). The data were normalized with 𝛽-actin expression and expressed as % of control. The ∗ indicates significant difference in
comparison to the control group (𝑝 < 0.05).
[37]. However, while NQO-1 is a stable protein (half-life
greater than 18 hours in wild type cells) [38], Nrf2 is a
highly unstable protein and its half-life is about 15min under
nonstress condition [39] to 100min under stress condition
[40]. In fact, according to Nguyen et al. [39], even in stress
condition, Nrf2 has a short life and is still subject to a high
rate of degradation. The same has been observed with the
HSP70, which has a half-life of approximately 2 hours [41].
This rapid degradation rate occurs, presumably, to prevent its
accumulation in an uncontrolledmanner [39] andmay be the
reason why we cannot observe differences in the levels of this
protein in our study.
We highlight that although our objective was to inves-
tigate effects of BF tea (crude aqueous extract) on liver
damage in diabetic mice, some points are extremely relevant
and deserve further attention in future investigations, in
particular, deeper analysis of the pancreas, serum insulin
concentration, analysis of BF compounds concentration in
the plasma, and the role/effect of their isolated bioactive
components.
5. Conclusion
Taken together, our observations suggested that diabeticmice
present an increase in liver oxidative damage and in pancreas
NQO-1 expression, which were modulated by BF treatment.
Since BF tea decreased liver oxidative injury but does not
change glycaemia, we believe that BF protective effect may be
attributed especially to its antioxidant capacity.
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